• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of December 11

News
Video

Here are the top 5 biosimilar articles for the week of December 11, 2023.

Number 5: Brian Biehn, senior director of biosimilar commercialization at Cencora, formerly known as AmerisourceBergen, recaps some of the major regulatory updates for biosimilars in the United States and makes predictions for how the market will develop in the years to come.

Number 4: After Humira’s patent expired in 2018 in the European Union (EU) and earlier this year in the US, 10 adalimumab biosimilars entered the market in the EU and 8 entered the market in the US. A review article discussed the characteristics of the available biosimilars to help clinicians navigate the various options with their patients.

Number 3: A study confirmed the effectiveness and safety of GP2017 in patients with inflammatory bowel disease (IBD) who were naïve to adalimumab or switched from the originator (Humira) or another adalimumab biosimilar.

Number 2: A simulation study estimated the impact of biosimilar substitution on total cost of care (TCOC) and provider financial performance in the final performance period of the Oncology Care Model.

Number 1: A report from IQVIA noted that Europe could miss out on €15 billion in cost savings by not having biosimilars for medications about to lose market exclusivity, shedding light on the implications for overall health care savings and ultimately, patient access.

To read all of these articles and more, visit centerforbiosimilars.com.

Recent Videos
Here are the top 5 biosimilar articles for the week of December 9, 2024.
Steve Pickette, PharmD
Here are the top 5 biosimilar articles for the week of December 2, 2024.
Here are the top 5 biosimilar articles for the week of November 25, 2024.
Here are the top 5 biosimilar articles for the week of November 18, 2024.
global biosimilars week join the movement
The Top 5 Biosimilar Articles of the Week.
Sophia Humphreys, PharmD
The Top 5 Biosimilar Articles of the Week.
The Top 5 Biosimilar Articles of the Week.
Related Content
© 2024 MJH Life Sciences

All rights reserved.